Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 20, No. 5, 2007
Issue release date: August 2007
Section title: Original Paper
Cell Physiol Biochem 2007;20:483–494
(DOI:10.1159/000107532)

Enhancement of P2Y6-Induced Cl- Secretion by IL-13 and Modulation of SK4 Channels Activity in Human Bronchial Cells

Dulong S. · Bernard K. · Ehrenfeld J.
Laboratoire de Physiologie Cellulaire et Moléculaire, Université de Nice-Sophia Antipolis
email Corresponding Author

Jordi Ehrenfeld

Laboratoire de Physiologie Cellulaire et Moléculaire

Université de Nice-Sophia Antipolis, CNRS, UMR 6548

arc Valrose, 28 avenue Valrose, 06108 Nice Cedex 2 (France)

Tel. +33 4 92 0768 36, Fax: +33 4 92 076834, E-Mail Jordi.EHRENFELD@unice.fr

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Abstract

Expression of functional P2Y6 receptors was demonstrated in primary cultures of human bronchial cells (NHBE cells). P2Y6 receptors were located only on the apical membranes of NHBE cells. Their stimulation by UDP induced a chloride secretion (short-circuit current) reflected by the development of two Isc components (Ifast and Ilate). A pharmacological characterization of those two Isc components showed the involvement of CaCC and CFTR channel activity in Ifast and Ilate respectively. Ifast was also found to be under control of basolateral SK4 channels. Indeed, inhibition of SK4 channels opening by clotrimazole dramatically reduced Ifast amplitude. The epithelial ion transporting phenotype depends on the cellular state of differentiation. As previously reported, we observed that Ultroser G increased the epithelial tightness and Na+-transport capacity while IL-13 switch the epithelial ion transport phenotype from a Na+-absorbing to a Cl--secreting one. In our study, we report for the first time a change in the K+ cell permeability associated to IL-13-induced cell differentiation. IL-13 treatment increased the-resting K+ permeability as well as the Ca2+-dependent K+ permeability stimulated by UDP or ionomycin. SK4 channels activity, underlying the Ca2+-dependent K+ permeability was in particular increased by IL-13. The on/off effect of IL-13 on P2Y6-induced Cl-secretion may help to identify the molecular determinants responsible for the CaCC channel activity.

© 2007 S. Karger AG, Basel


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: April 29, 2008
Issue release date: August 2007

Number of Print Pages: 12
Number of Figures: 0
Number of Tables: 0

ISSN: 1015-8987 (Print)
eISSN: 1421-9778 (Online)

For additional information: http://www.karger.com/CPB


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.